Literature DB >> 34202503

COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences.

Shih-Lung Cheng1,2, Ching-Hsiung Lin3,4,5.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) report is one of the most frequently used documents for managing COPD patients worldwide. A survey was conducted across country-level members of Asia-Pacific Society of Respiratory (APSR) for collecting an updated version of local COPD guidelines, which were implemented in each country. This is the first report to summarize the similarities and differences among the COPD guidelines across the Asia-Pacific region. The degree of airflow limitation, assessment of COPD severity, management, and pharmacologic therapy of stable COPD will be reviewed in this report.

Entities:  

Keywords:  Asia; COPD guideline

Year:  2021        PMID: 34202503     DOI: 10.3390/diagnostics11071153

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  29 in total

1.  COPD in Japan: the Nippon COPD Epidemiology study.

Authors:  Yoshinosuke Fukuchi; Masaharu Nishimura; Masakazu Ichinose; Mitsuru Adachi; Atsushi Nagai; Takayuki Kuriyama; Keiji Takahashi; Koichi Nishimura; Shinichi Ishioka; Hisamichi Aizawa; Carol Zaher
Journal:  Respirology       Date:  2004-11       Impact factor: 6.424

2.  Is the new GOLD classification applicable in China?

Authors:  Ning Shen; Bei He
Journal:  Lancet Glob Health       Date:  2013-10-02       Impact factor: 26.763

3.  Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.

Authors:  Peter Lange; Jacob Louis Marott; Jørgen Vestbo; Kim Rose Olsen; Truls Sylvan Ingebrigtsen; Morten Dahl; Børge Grønne Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2012-09-20       Impact factor: 21.405

4.  Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study.

Authors:  Nathania A J B Cooksley; David Atkinson; Guy B Marks; Brett G Toelle; David Reeve; David P Johns; Michael J Abramson; Deborah L Burton; Alan L James; Richard Wood-Baker; E Haydn Walters; A Sonia Buist; Graeme P Maguire
Journal:  Respirology       Date:  2015-02-22       Impact factor: 6.424

5.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

6.  Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Authors:  Christine R Jenkins; Paul W Jones; Peter M A Calverley; Bartolome Celli; Julie A Anderson; Gary T Ferguson; Julie C Yates; Lisa R Willits; Jörgen Vestbo
Journal:  Respir Res       Date:  2009-06-30

7.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Authors:  Bartolomé R Celli; Nicola E Thomas; Julie A Anderson; Gary T Ferguson; Christine R Jenkins; Paul W Jones; Jørgen Vestbo; Katharine Knobil; Julie C Yates; Peter M A Calverley
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

8.  Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.

Authors:  Vladimir Koblizek; Jan Chlumsky; Vladimir Zindr; Katerina Neumannova; Jakub Zatloukal; Jaroslav Zak; Vratislav Sedlak; Jana Kocianova; Jaromir Zatloukal; Karel Hejduk; Sarka Pracharova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2013-05-24       Impact factor: 1.245

9.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

10.  Prevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination survey.

Authors:  Hwayeon Park; Se Young Jung; Kiheon Lee; Woo Kyung Bae; Keehyuck Lee; Jong-Soo Han; Sarah Kim; Seryung Choo; Jin-Mook Jeong; Hyun-Ray Kim; Hyun Jung Ro; Hansol Jeong
Journal:  Korean J Fam Med       Date:  2015-05-22
View more
  4 in total

1.  Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator.

Authors:  Wei Wang; Qing Yang; Qiufen Xun; Xiaoqun Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-09       Impact factor: 2.650

Review 2.  Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts' review.

Authors:  Raja Dhar; Deepak Talwar; Sundeep Salvi; B V Muralimohan; Sagar Panchal; Saiprasad Patil; Sagar Bhagat; Nishtha Khatri; Hanmant Barkate
Journal:  ERJ Open Res       Date:  2022-03-28

3.  Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial.

Authors:  Thomas Bradbury; Gian Luca Di Tanna; Anish Scaria; Allison Martin; Fu-Qiang Wen; Nan-Shan Zhong; Jin-Ping Zheng; Peter J Barnes; Bartolome Celli; Norbert Berend; Christine R Jenkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-05

4.  Machine Learning Approaches for Predicting Acute Respiratory Failure, Ventilator Dependence, and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Kuang-Ming Liao; Chung-Feng Liu; Chia-Jung Chen; Yu-Ting Shen
Journal:  Diagnostics (Basel)       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.